🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1b/2a, open-label, multi-center, dose-escalation and safety...
Status
Completed
Location
Site 2644 University of California, Irvine
Start Date
2018-06-19
Trial ID
NCT03294083
Treatments Being Tested
This is a neoadjuvant Phase 2a, open-label trial in patients with metastati...
Status
Terminated
Location
Ottawa Hospital and Research Institute (OHRI)
Start Date
2011-10
Trial ID
NCT01329809
Treatments Being Tested
This is a Phase I, open-label, dose-escalation trial in patients with advan...
Status
Completed
Location
Billings Clinic
Start Date
2008-06
Trial ID
NCT00625456
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and effi...
Status
Completed
Location
Mayo Clinic
Start Date
2012-01
Trial ID
NCT01394939
Treatments Being Tested
This is a study to Evaluate the Safety and Efficacy of the Combination of t...
Status
Terminated
Location
Site No 0102
Start Date
2017-07-27
Trial ID
NCT03071094
Treatments Being Tested
The purpose of this pilot safety study is to evaluate the safety and tolera...
Status
Completed
Location
Pusan National University Hospital
Start Date
2009-05-26
Trial ID
NCT01171651
Background: * Immune-based approaches in colorectal cancer have unfortunat...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-12-07
Trial ID
NCT03206073
Treatments Being Tested
This is a Phase I, open-label, dose-escalation trial of JX-594 (Pexa-Vec) i...
Status
Completed
Location
Cincinnati Children's Hospital Medical Center
Start Date
2010-08
Trial ID
NCT01169584
Treatments Being Tested
The purpose of this pilot safety study is to evaluate the safety and tolera...
Status
Completed
Location
Samsung Medical Center
Start Date
2010-09-08
Trial ID
NCT01380600
Treatments Being Tested
The success of anti-CTLA4 therapy has inaugurated a paradigm shift in oncol...
Status
Completed
Location
Institut Bergonie
Start Date
2017-01-03
Trial ID
NCT02977156
Treatments Being Tested